Xtl Biopharmaceuticals (XTLB) Intangibles (2010 - 2024)
Xtl Biopharmaceuticals (XTLB) posted quarterly Intangibles of $3.8 million for Q4 2024, up 904.21% year-on-year from $380000.0 in Q1 2024, and up 904.21% on a QoQ basis from $380000.0 in Q2 2024.
Xtl Biopharmaceuticals (XTLB) Intangibles (2010 - 2024) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Intangibles for 15 consecutive years, with $3.8 million the latest figure, recorded in Q4 2024.
- Quarterly Intangibles rose 904.21% year-over-year to $3.8 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.8 million (up 904.21% YoY) and the FY2024 annual result came in at $3.8 million, up 904.21% from the prior year.
- Intangibles advanced to $3.8 million in Q4 2024 per XTLB's latest filing, from $380000.0 in the prior quarter.
- Over the last five years, Intangibles for XTLB reached as high as $3.8 million in Q4 2024 and fell as low as $380000.0 in Q4 2020.
- A 5-year average of $644307.7 and a median of $380000.0 in 2020 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2020 — Intangibles changed 0.0% — and 2024, when it jumped 904.21%.
- Year by year, Intangibles stood at $380000.0 in 2020, then changed by 0.0% to $380000.0 in 2021, then changed by 0.0% to $380000.0 in 2022, then changed by 0.0% to $380000.0 in 2023, then soared by 904.21% to $3.8 million in 2024.
- According to Business Quant data, Intangibles over the past three periods registered $3.8 million, $380000.0, and $380000.0 for Q4 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | - |
| 10 | Xtl Biopharmaceuticals | 2.51 Bn | 2.51 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.82 Mn |
| Jun 30, 2024 | 380,000.00 |
| Mar 31, 2024 | 380,000.00 |
| Dec 31, 2023 | 380,000.00 |
| Sep 30, 2023 | 380,000.00 |
| Jun 30, 2023 | 380,000.00 |
| Mar 31, 2023 | 380,000.00 |
| Dec 31, 2022 | 380,000.00 |
| Sep 30, 2022 | 380,000.00 |
| Jun 30, 2022 | 380,000.00 |
| Dec 31, 2021 | 380,000.00 |
| Jun 30, 2021 | 380,000.00 |
| Dec 31, 2020 | 380,000.00 |
| Dec 31, 2019 | 380,000.00 |
| Dec 31, 2018 | 380,000.00 |
| Sep 30, 2018 | 380,000.00 |
| Dec 31, 2017 | 380,000.00 |
| Dec 31, 2016 | 253,000.00 |
| Jun 30, 2016 | 1.10 Mn |
| Dec 31, 2015 | 1.04 Mn |